A Comparative Study of Normalized Residual Activity and Standard Parameters in 99mTc-DTPA Diuretic Renography:
Improving Obstruction Diagnosis in 99mTc-DTPA Diuretic Renography: A Comparative Study of Normalized Residual Activity and Standard Parameters
Panoramica dello studio
Stato
Stato
Condizioni
Condizioni
Intervento / Trattamento
Intervento / Trattamento
Descrizione dettagliata
Urinary tract obstruction is a common clinical condition encountered in both pediatric and adult populations and represents a significant cause of potentially reversible renal impairment. Persistent obstruction to urinary outflow may result in progressive deterioration of renal function, recurrent urinary tract infections, nephrolithiasis, hypertension, and ultimately irreversible renal damage if diagnosis and appropriate intervention are delayed. Consequently, early identification of clinically significant obstruction is essential to preserve renal function and optimize patient outcomes. However, differentiating true functional obstruction from non-obstructive dilatation remains one of the major diagnostic challenges in daily clinical practice, particularly in patients presenting with hydronephrosis detected by ultrasonography or other anatomical imaging modalities. (1-3) Although ultrasonography, computed tomography (CT), and magnetic resonance urography provide excellent anatomical information regarding the urinary collecting system, they cannot always determine whether dilatation is associated with functionally significant obstruction. Hydronephrosis may occur in the absence of obstruction due to physiological or congenital causes, including an extrarenal pelvis, non-obstructive pelvicalyceal dilatation, vesicoureteral reflux, or postoperative changes. Therefore, anatomical imaging alone is frequently insufficient for determining the need for surgical intervention, emphasizing the importance of functional assessment of urinary drainage. (1-3)
Diuretic renography has become the established functional imaging technique for evaluating suspected urinary tract obstruction. It provides simultaneous assessment of renal perfusion, differential renal function, and urinary drainage after pharmacologically induced diuresis, thereby enabling distinction between obstructive and non-obstructive dilatation. Among the radiopharmaceuticals used in renal scintigraphy, 99mTc-diethylenetriamine pentaacetic acid (99mTc-DTPA) remains widely used because it is eliminated exclusively by glomerular filtration, allowing for the estimation of glomerular filtration rate (GFR) in addition to assessing urinary drainage within a single examination. (1,4)
Interpretation of diuretic renography has traditionally relied on several qualitative and quantitative parameters, including visual assessment of the renogram curve, time to peak activity (Tmax), half-time of tracer clearance (T½), post-diuretic washout, and differential renal function. Although these parameters remain fundamental components of routine clinical practice, each has recognized limitations. Factors such as impaired renal function, severe pelvicalyceal dilatation, inadequate hydration, bladder distension, patient motion, and variations in diuretic administration protocols may significantly influence tracer washout and reduce diagnostic accuracy. Consequently, equivocal or false-positive interpretations may occur, particularly in markedly dilated but non-obstructed collecting systems. (1,4,7)
To overcome these limitations, several alternative quantitative indices have been proposed to improve the assessment of urinary drainage. One of the most promising parameters is Normalized Residual Activity (NORA), which represents the proportion of residual renal tracer activity at a specified time relative to the initial renal uptake. Unlike conventional washout measurements, NORA is less dependent on renal function and collecting system compliance and provides a simple quantitative estimate of residual tracer retention. Previous investigations have demonstrated that NORA improves discrimination between true urinary tract obstruction and non-obstructive dilatation, particularly when measured on post-micturition images. (5-7)
Recent evidence has suggested that NORA demonstrates superior diagnostic specificity compared with conventional renographic interpretation, reducing the number of equivocal examinations and minimizing unnecessary surgical intervention. Beatović et al. reported that post-micturition NORA correctly reclassified the majority of indeterminate or false-positive renographic studies while maintaining excellent diagnostic accuracy for urinary outflow obstruction. Such findings support the incorporation of quantitative drainage parameters into routine renographic interpretation; however, the clinical utility of NORA has not yet been universally adopted and remains insufficiently evaluated across different patient populations and imaging protocols. (5,7)
Given the continuing reliance on conventional renographic parameters in many nuclear medicine departments and the increasing interest in quantitative assessment of renal drainage, further evaluation of NORA is warranted. Comparing NORA with established renographic indices may
provide additional evidence regarding its diagnostic value and its potential role in improving the accuracy of diuretic renography for patients with suspected urinary tract obstruction. Therefore, the present study aims to compare the diagnostic performance of Normalized Residual Activity with conventional renographic parameters in 99mTc-DTPA diuretic renography for the diagnosis of urinary tract obstruction.
Additionally, Cortical Transit Time (CTT) is an effective metric for distinguishing between obstructed and non-obstructed kidneys. A delayed CTT flags kidneys at risk of functional deterioration if surgery is delayed, whereas a normal CTT signals that the kidney is safe from decline, independent of T_(1/2) values or drainage curve patterns. Ultimately, a normal CTT rules out obstruction as effectively as a favorable diuretic renogram drainage pattern [1].
Tipo di studio
Tipo di studio
Iscrizione (Stimato)
Iscrizione
Contatti e Sedi
Contatto studio
Contatto studio
- Nome: Mahytab Abdelhafez Ezzat, Bachelor
- Numero di telefono: 0201096549745
- Email: mahytababdelhafezmaster@gmail.com
Criteri di partecipazione
Criteri di ammissibilità
Criteri di ammissibilità
Età idonea allo studio
- Bambino
- Adulto
- Adulto più anziano
Accetta volontari sani
Metodo di campionamento
Popolazione di studio
Descrizione
Inclusion Criteria:
Patients fulfilling all of the following criteria will be eligible for inclusion:
- Pediatric or adult patients referred for 99mTc-DTPA diuretic renography because of suspected urinary tract obstruction.
- Availability of a clinical reference standard (e.g., confirmation of obstruction via surgical findings/pyeloplasty, or proven non-obstruction via stable long-term clinical and radiological follow-up of at least 6-12 months).
Exclusion Criteria:
Patients meeting any of the following criteria will be excluded:
- Patients with severe renal impairment.
- Patients with renal congenital anomalies e.g. horseshoe kidneys
- Technical failure during the scan, including severe patient motion artifacts or failure to properly administer the diuretic
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
Cosa sta misurando lo studio?
Misure di risultato primarie
Misure di risultato primarie
Misura del risultato |
Lasso di tempo |
|---|---|
|
Diagnostic performance of Normalized Residual Activity (NORA) Versus conventional renographic parameters in 99mTc-DTPA diuretic renography in the diagnosis of urinary tract obstruction.
Lasso di tempo: approximately 2 years
|
approximately 2 years
|
Misure di risultato secondarie
Misure di risultato secondarie
Misura del risultato |
Lasso di tempo |
|---|---|
|
• The ability of NORA to differentiate true urinary tract obstruction from non-obstructive urinary tract dilatation.
Lasso di tempo: approximately 2 years
|
approximately 2 years
|
|
Clinical usefulness of incorporating NORA into the routine interpretation of 99mTc-DTPA diuretic renography.
Lasso di tempo: approximately 2 years
|
approximately 2 years
|
|
The Predictive value of cortical transit time "CTT" for the deterioration in the function of the hydronephrotic kidney.
Lasso di tempo: approximately 2 years
|
approximately 2 years
|
Collaboratori e investigatori
Sponsor
Sponsor
Pubblicazioni e link utili
Pubblicazioni generali
- Jochumsen MR, Bouchelouche K. PSMA PET/CT for Primary Staging of Prostate Cancer - An Updated Overview. Semin Nucl Med. 2024 Jan;54(1):39-45. doi: 10.1053/j.semnuclmed.2023.07.001. Epub 2023 Jul 22.
- Farrell MB, Banks KP, Peacock JG. Diuretic Renal Scintigraphy. J Nucl Med Technol. 2022 Dec 7;50(4):319-321. doi: 10.2967/jnmt.122.264804. No abstract available.
- Taylor AT, Brandon DC, de Palma D, Blaufox MD, Durand E, Erbas B, Grant SF, Hilson AJW, Morsing A. SNMMI Procedure Standard/EANM Practice Guideline for Diuretic Renal Scintigraphy in Adults With Suspected Upper Urinary Tract Obstruction 1.0. Semin Nucl Med. 2018 Jul;48(4):377-390. doi: 10.1053/j.semnuclmed.2018.02.010. Epub 2018 Mar 16. No abstract available.
- Expert Panel on Gastrointestinal Imaging; Bashir MR, Horowitz JM, Kamel IR, Arif-Tiwari H, Asrani SK, Chernyak V, Goldstein A, Grajo JR, Hindman NM, Kamaya A, McNamara MM, Porter KK, Solnes LB, Srivastava PK, Zaheer A, Carucci LR. ACR Appropriateness Criteria(R) Chronic Liver Disease. J Am Coll Radiol. 2020 May;17(5S):S70-S80. doi: 10.1016/j.jacr.2020.01.023.
Studiare le date dei record
Studia le date principali
Inizio studio (Stimato)
Inizio studio
Completamento primario (Stimato)
Completamento primario
Completamento dello studio (Stimato)
Completamento dello studio
Date di iscrizione allo studio
Primo inviato
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Primo Inserito
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento pubblicato
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
Altri numeri di identificazione dello studio
- NORA in diuretic renography
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .